XML 89 R74.htm IDEA: XBRL DOCUMENT v3.26.1
Revenue Recognition - Schedule of Contract Revenue Recognized (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Disaggregation of Revenue [Line Items]    
Total contract revenue $ 2,153 $ 3,616
Pharmaceutical Development Segment    
Disaggregation of Revenue [Line Items]    
Total contract revenue 2,153 3,616
License Agreement | Pharmaceutical Development Segment    
Disaggregation of Revenue [Line Items]    
Total contract revenue 0 49
Pharmaceutical development and other | Pharmaceutical Development Segment    
Disaggregation of Revenue [Line Items]    
Total contract revenue $ 2,153 $ 3,567